Clinical Trial Update: A Study of Serum Folate Levels in Patients Treated With Olaparib [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating serum folate levels in patients with ovarian or breast cancer treated with olaparib; results are now posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Ovarian Cancer

Drugs mentioned

• Lynparza (olaparib)

Snippet

Sponsor: Rush University Medical Center | Conditions: Ovarian Cancer, Breast Cancer | Phase 4 | Status: COMPLETED | Results posted: 2025-11-21